Boceprevir and telaprevir: new treatments for chronic hepatitis C

    loading  Checking for direct PDF access through Ovid

Abstract

Boceprevir and telaprevir are new antiviral drugs indicated for the treatment of chronic hepatitis C genotype 1 infection. In our New products review, Steve Chaplin presents the clinical data relating to their efficacy and adverse effects and Professor Geoffrey Dusheiko discusses their place in treatment.

Related Topics

    loading  Loading Related Articles